Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Ovarian Epithelial Cancer Recurrent × Clear all

Status

Sponsor Class

Study Type

Interventional 3 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1991 Neoplasms 1807 Lung Neoplasms 966 Colorectal Neoplasms 915 Prostatic Neoplasms 803 Carcinoma, Non-Small-Cell Lung 659 Carcinoma, Hepatocellular 598 Stomach Neoplasms 534 Pancreatic Neoplasms 524 Head and Neck Neoplasms 387 Ovarian Neoplasms 381 Colonic Neoplasms 376 Rectal Neoplasms 365 Uterine Cervical Neoplasms 351 Esophageal Neoplasms 313 Brain Neoplasms 298 Neoplasm Metastasis 285 Melanoma 274 Multiple Myeloma 272 Precursor Cell Lymphoblastic Leukemia-Lymphoma 260 Urinary Bladder Neoplasms 254 Leukemia, Myeloid, Acute 239 Lymphoma 236 Hematologic Neoplasms 225 Liver Neoplasms 224 Endometrial Neoplasms 216 Disease 204 Glioma 197 Recurrence 195 Carcinoma, Renal Cell 194

Interventions

liposomal doxorubicin 1 Trabectedin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡